Literature DB >> 4980929

Hemolytic anemia with impaired hexokinase activity.

A S Keitt.   

Abstract

Analyses of key glycolytic intermediates in freshly drawn red cells from six related individuals suggest that decreased hexokinase activity underlies the hemolytic process in the two members with overt hemolysis. Low red cell glucose 6-phosphate (G6P) was observed not only in the anemic patients but in the presumptive heterozygotes as well and served as a useful marker for the presence of the trait. Hexokinase activity was labile in distilled water hemolysates but was only slightly low when protected by glucose, mercaptoethanol, and ethylenediaminetetraacetate (EDTA). Normal red cell hexokinase was demonstrated to be dependent on glucose for maintenance of activity after heating to 45 degrees C. The cells of the proposita are unable to utilize glucose efficiently at glucose concentrations lower than 0.2 mmole/liter whereas normal cells maintain linear glucose consumption to at least 0.05 mM glucose. These qualitative abnormalities could result from the presence of a mutant hexokinase with an abnormally reactive sulfhydryl group and altered substrate affinity in the red cells of this kindred.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4980929      PMCID: PMC297452          DOI: 10.1172/JCI106165

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  HEREDITARY HEMOLYTIC ANEMIA WITH TRIOSEPHOSPHATE ISOMERASE DEFICIENCY.

Authors:  A S SCHNEIDER; W N VALENTINE; M HATTORI; H L HEINS
Journal:  N Engl J Med       Date:  1965-02-04       Impact factor: 91.245

2.  EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN.

Authors:  O H LOWRY; J V PASSONNEAU; F X HASSELBERGER; D W SCHULZ
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

3.  Automatic pH regulation of cell suspensions by a gasometric pH-stat.

Authors:  B VESTERGAARD-BOGIND
Journal:  Scand J Clin Lab Invest       Date:  1962       Impact factor: 1.713

4.  Erythrocyte metabolism. V. Levels of glycolytic enzymes and regulation of glycolysis.

Authors:  R G CHAPMAN; M A HENNESSEY; A M WALTERSDORPH; F M HUENNEKENS; B W GABRIO
Journal:  J Clin Invest       Date:  1962-06       Impact factor: 14.808

5.  Localization of interaction sites in multi-component transfer systems: theorems derived from analogues.

Authors:  B CHANCE; W HOLMES; J HIGGINS; C M CONNELLY
Journal:  Nature       Date:  1958-11-01       Impact factor: 49.962

6.  The inhibition of hexokinase by disulphides.

Authors:  R Nesbakken; L Eldjarn
Journal:  Biochem J       Date:  1963-06       Impact factor: 3.857

7.  Phosphorus compounds in the human erythrocyte.

Authors:  G R Bartlett
Journal:  Biochim Biophys Acta       Date:  1968-03-11

8.  Biochemical variants of glucose-6-phosphate dehydrogenase giving rise to congenital nonspherocytic hemolytic disease.

Authors:  E Beutler; C K Mathai; J E Smith
Journal:  Blood       Date:  1968-02       Impact factor: 22.113

9.  Hemoglobin sabine beta 91 (f 7) leu to pro. An unstable variant causing severe anemia with inclusion bodies.

Authors:  R G Schneider; S Ueda; J B Alperin; B Brimhall; R T Jones
Journal:  N Engl J Med       Date:  1969-04-03       Impact factor: 91.245

10.  Multiple hexokinases of rat tissues. Purification and comparison of soluble forms.

Authors:  L Grossbard; R T Schimke
Journal:  J Biol Chem       Date:  1966-08-10       Impact factor: 5.157

View more
  10 in total

Review 1.  Advances in hereditary red cell enzyme anomalies.

Authors:  A Kahn; J C Kaplan; J C Dreyfus
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Glucose metabolism in fibroblasts from patients with erythrocyte hexokinase deficiency.

Authors:  M Magnani; L Chiarantini; V Stocchi; M Dachà; G Fornaini
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

3.  Human erythrocyte hexokinase deficiency. Characterization of a mutant enzyme with abnormal regulatory properties.

Authors:  G Rijksen; G E Staal
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

4.  Hemolytic anemia and hexokinase deficiency associated with malformations.

Authors:  K M Goebel; W D Gassel; F D Goebel; H Kaffarnik
Journal:  Klin Wochenschr       Date:  1972-09-01

5.  A new metabolic muscle disease due to abnormal hexokinase activity.

Authors:  K R Poulton; S Nightingale
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

6.  Loss of the clock protein PER2 shortens the erythrocyte life span in mice.

Authors:  Qi Sun; Yue Zhao; Yunxia Yang; Xiao Yang; Minghui Li; Xi Xu; Dan Wen; Junsong Wang; Jianfa Zhang
Journal:  J Biol Chem       Date:  2017-06-12       Impact factor: 5.157

7.  Metabolic alterations in the human erythrocyte produced by increases in glucose concentration. The role of the polyol pathway.

Authors:  S F Travis; A D Morrison; R S Clements; A I Winegrad; F A Oski
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

Review 8.  [Enzyme deficiencies in glycolysis and nucleotide metabolism of red blood cells in nonspherocytic hemolytic anemia (author's transl)].

Authors:  H D Waller; H C Benöhr
Journal:  Klin Wochenschr       Date:  1976-09-01

9.  Dimethyl adipimidate: a new antisickling agent.

Authors:  B H Lubin; V Pena; W C Mentzer; E Bymun; T B Bradley; L Packer
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

10.  Donor genetic and nongenetic factors affecting red blood cell transfusion effectiveness.

Authors:  Nareg H Roubinian; Sarah E Reese; Hannah Qiao; Colleen Plimier; Fang Fang; Grier P Page; Ritchard G Cable; Brian Custer; Mark T Gladwin; Ruchika Goel; Bob Harris; Jeanne E Hendrickson; Tamir Kanias; Steve Kleinman; Alan E Mast; Steven R Sloan; Bryan R Spencer; Steven L Spitalnik; Michael P Busch; Eldad A Hod
Journal:  JCI Insight       Date:  2022-01-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.